Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) FCF Margin (2016 - 2022)

Historic FCF Margin for Aptevo Therapeutics (APVO) over the last 8 years, with Q1 2022 value amounting to 164.32%.

  • Aptevo Therapeutics' FCF Margin rose 1535200.0% to 164.32% in Q1 2022 from the same period last year, while for Dec 2022 it was 675.21%, marking a year-over-year decrease of 4930400.0%. This contributed to the annual value of 676.01% for FY2022, which is 4938400.0% down from last year.
  • Aptevo Therapeutics' FCF Margin amounted to 164.32% in Q1 2022, which was up 1535200.0% from 109.09% recorded in Q4 2021.
  • In the past 5 years, Aptevo Therapeutics' FCF Margin registered a high of 56.47% during Q4 2019, and its lowest value of 979.49% during Q2 2020.
  • Over the past 5 years, Aptevo Therapeutics' median FCF Margin value was 215.91% (recorded in 2019), while the average stood at 328.52%.
  • Per our database at Business Quant, Aptevo Therapeutics' FCF Margin tumbled by -7635800bps in 2020 and then surged by 8044400bps in 2021.
  • Over the past 5 years, Aptevo Therapeutics' FCF Margin (Quarter) stood at 773.64% in 2018, then surged by 93bps to 56.47% in 2019, then tumbled by -357bps to 258.03% in 2020, then soared by 58bps to 109.09% in 2021, then crashed by -51bps to 164.32% in 2022.
  • Its last three reported values are 164.32% in Q1 2022, 109.09% for Q4 2021, and 169.74% during Q3 2021.